News & Publications

Dear friends of Merkel cell carcinoma research, As we enter this season of gratitude and reflection, I would like to thank you for your partnership. I am pleased to share our annual holiday letter, which describes some of the progress that you have made possible this year. If you would like to conti...

Terry Bradshaw's recent diagnosis of Merkel cell carcinoma has brought some awareness of MCC to a larger number of people. This article, written by a journalist-physician, attempts to provide some background on his situation, as well as on MCC more broadly. Such information can clearly be useful for...

The immune stimulating drug combination called ‘ipi-nivo’ (IPIlimumab or Yervoy targets CTLA4 while NIVOlumab or Opdivo targets PD1) has an established role in melanoma, but less is known about using this double therapy in Merkel cell carcinoma. A major study published in the Lancet and led by K...

The University of Washington's Nghiem Lab held its annual Merkel CELLebration & Dinner on Monday, Sept. 12, 2022, at the UW Medicine Research Campus in Seattle’s South Lake Union neighborhood. Each year the Nghiem Lab hosts the event to share the latest advances in the treatment of Merkel cell car...

Several faculty, trainees and researchers representing UW Dermatology presented their research at the SID Annual Meeting in Portland, Oregon from May 18-21, 2022. Each year, the Society for Investigative Dermatology (SID)’s Annual Meeting invites a diverse group of researchers and clinicians, as w...

The UW Division of Dermatology hosted the 2nd International Symposium on Merkel Cell Carcinoma in Seattle, WA, from April 25-26, 2022. The two-day hybrid (in-person and virtual) event held at the Graduate Hotel brought together over 140 thought leaders, active investigators, faculty and trainees in ...

The 16th Annual MCC Multi-center Interest Group (MMIG) Meeting took place on March 25, 2022 at the American Academy of Dermatology Annual Meeting in Boston, MA. Here we summarize talks given by Lisa Zaba, MD, PhD, Lindsay Gunnell, MD, Sophia Shalhout, PhD, Mackenzie Martin, BA, Anna Szumera-Cieckiew...

Congratulations to several members of the Nghiem Lab Research Team whose recent proposal was selected to receive over $1.2 million in award funding through The Mark Foundation to support their innovative Merkel cell carcinoma (MCC) research. The research team includes Peter Goff, MD, PhD, Senior...

Congratulations to UW Dermatology’s Nghiem Lab Research Team, and partners from around the world, who have recently been awarded a $4 million grant from Innovation Fund Denmark (IFD) to develop and clinically test the ImmPACT cell product in Merkel cell carcinoma. The project will explore the po...

MCC made it into the NY Times in the form of this fascinating medical mystery story. A ‘paraneoplastic syndrome’ is when a tumor causes a process to happen in the body indirectly, such as via an immune response to the tumor that attacks another part of the body (as happened here) or because the ...